Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xilio Therapeutics (XLO)
NASDAQ:XLO
RESEARCH TOOLSreports
Holding XLO?
Track your performance easily
Xilio Therapeutics (XLO) Ownership Overview
70.70% Insiders
3.01% Mutual Funds
21.29% Other Institutional Investors
― ETFs
5.00% Public Companies and
Individual Investors
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. , 70.70% is owned by Insiders, and 5.00% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 03, 2024 | Gilead Sciences Inc >10% Owner | xxxxxxxxxxxxx | $368790 |
| Feb 09, 2024 | Atlas Venture Fund Xi, L.p. >10% Owner | xxxxxxxxxxxxx | $640 |
| Jan 16, 2024 | Atlas Venture Fund Xi, L.p. >10% Owner | xxxxxxxxxxxxx | $3600 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 899,587 | Institution | 2.44% | 917,579 | |
| 899,587 | Institution | 2.44% | 917,579 | |
| 105,481 | Institution | 0.29% | 107,591 | |
| 75,378 | Institution | 0.20% | 76,886 | |
| 63,226 | Institution | 0.17% | 64,491 | |
| 14,714 | Institution | 0.04% | 15,008 | |
| 11,925 | Institution | 0.03% | 12,164 | |
| 2,551 | Institution | <0.01% | 2,602 | |
| 1,088 | Institution | <0.01% | 1,110 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 899,587 | Institution | 2.44% | 917,579 | |
| 105,481 | Institution | 0.29% | 107,591 | |
| 75,378 | Institution | 0.20% | 76,886 | |
| 14,714 | Institution | 0.04% | 15,008 | |
| 11,925 | Institution | 0.03% | 12,164 | |
| 2,551 | Institution | <0.01% | 2,602 | |
| 1,088 | Institution | <0.01% | 1,110 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 739,563 | Institution | 2.00% | 798,728 | |
| 160,024 | Institution | 0.43% | 172,826 | |
| 63,226 | Institution | 0.17% | 64,491 |
FAQ
Who Owns Xilio Therapeutics (XLO)?
According to the latest TipRanks data, approximately 21.29% of the company's stock is held by institutional investors, 70.70% is held by insiders, and 5.00% is held by retail investors.
What percentage of Xilio Therapeutics (XLO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.29% of Xilio Therapeutics (XLO) stock is held by institutional investors.
What percentage of Xilio Therapeutics (XLO) stock is held by retail investors?
According to the latest TipRanks data, approximately 5.00% of Xilio Therapeutics (XLO) stock is held by retail investors.
Who owns the most shares of Xilio Therapeutics (XLO)?
Vanguard owns the most shares of Xilio Therapeutics (XLO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.